Weisse et al., 2009 - Google Patents
Investigations on topically applied vitamin A loaded amphiphilic cyclodextrin nanocapsulesWeisse et al., 2009
View PDF- Document ID
- 6443609536066264741
- Author
- Weisse S
- Kalimouttou S
- Lahiani-Skiba M
- Djedaini-Pilard F
- Perly B
- Skiba M
- Publication year
- Publication venue
- Journal of Nanoscience and Nanotechnology
External Links
Snippet
A new cholesteryl-cyclodextrin derivative, obtained by grafting a single cholesterol on a cyclodextrin, was proved suitable for the manufacture of nanocapsules. The chemical structure of Chol- CD-Ac was assessed using high resolution 1H-NMR. These …
- 239000002088 nanocapsule 0 title abstract description 61
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/51—Nanocapsules; Nanoparticles
- A61K9/5107—Excipients; Inactive ingredients
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives
- A61K47/48—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives the non-active ingredient being chemically bound to the active ingredient, e.g. polymer drug conjugates
- A61K47/48769—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives the non-active ingredient being chemically bound to the active ingredient, e.g. polymer drug conjugates the conjugate being characterized by a special physical or galenical form
- A61K47/48961—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives the non-active ingredient being chemically bound to the active ingredient, e.g. polymer drug conjugates the conjugate being characterized by a special physical or galenical form the conjugate being in the form of a host-guest, i.e. being an inclusion complex, e.g. clathrate, cavitate, fullerene
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/107—Emulsions; Emulsion preconcentrates; Micelles
- A61K9/1075—Microemulsions or submicron emulsions; Preconcentrates or solids thereof; Micelles, e.g. made of phospholipids or block copolymers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K8/00—Cosmetic or similar toilet preparations
- A61K8/18—Cosmetic or similar toilet preparations characterised by the composition
- A61K8/72—Cosmetic or similar toilet preparations characterised by the composition containing organic macromolecular compounds
- A61K8/73—Polysaccharides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K8/00—Cosmetic or similar toilet preparations
- A61K8/02—Cosmetic or similar toilet preparations characterised by special physical form
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Sang et al. | Comparison of three water-soluble polyphosphate tripolyphosphate, phytic acid, and sodium hexametaphosphate as crosslinking agents in chitosan nanoparticle formulation | |
| Zhao et al. | Encapsulation of anthocyanin in liposomes using supercritical carbon dioxide: Effects of anthocyanin and sterol concentrations | |
| Lavasanifar et al. | Micelles self-assembled from poly (ethylene oxide)-block-poly (N-hexyl stearate L-aspartamide) by a solvent evaporation method: effect on the solubilization and haemolytic activity of amphotericin B | |
| Freag et al. | Self-assembled phospholipid-based phytosomal nanocarriers as promising platforms for improving oral bioavailability of the anticancer celastrol | |
| Numata et al. | A slow-release system of bacterial cellulose gel and nanoparticles for hydrophobic active ingredients | |
| Çirpanli et al. | Comparative evaluation of polymeric and amphiphilic cyclodextrin nanoparticles for effective camptothecin delivery | |
| KR100469699B1 (en) | Cyclodextrins preferentially substituted on their primary face by acid or amine functions | |
| Laouini et al. | Preparation, characterization and applications of liposomes: state of the art | |
| Kumari et al. | Nanoencapsulation and characterization of Albizia chinensis isolated antioxidant quercitrin on PLA nanoparticles | |
| Piel et al. | Betamethasone-in-cyclodextrin-in-liposome: the effect of cyclodextrins on encapsulation efficiency and release kinetics | |
| Gao et al. | Supramolecular nanogels fabricated via host–guest molecular recognition as penetration enhancer for dermal drug delivery | |
| Yuan et al. | Strategic approaches for improving entrapment of hydrophilic peptide drugs by lipid nanoparticles | |
| Jena et al. | Polymeric micelles of amphiphilic graft copolymer of α-tocopherol succinate-g-carboxymethyl chitosan for tamoxifen delivery: Synthesis, characterization and in vivo pharmacokinetic study | |
| Marianecci et al. | Niosomes encapsulating ibuprofen–cyclodextrin complexes: preparation and characterization | |
| Kim et al. | High paclitaxel-loaded and tumor cell-targeting hyaluronan-coated nanoemulsions | |
| Elsayad et al. | Chitosan caged liposomes for improving oral bioavailability of rivaroxaban: in vitro and in vivo evaluation | |
| Pariot et al. | Cross-linked β-cyclodextrin microcapsules: preparation and properties | |
| Schwarz et al. | Decrease of liposomal size and retarding effect on fluconazole skin permeation by lysine derivatives | |
| Alkhatib et al. | Overcoming the hydrophilicity of bacterial nanocellulose: Incorporation of the lipophilic coenzyme Q10 using lipid nanocarriers for dermal applications | |
| Garcia et al. | Improved nonclinical pharmacokinetics and biodistribution of a new PPAR pan-agonist and COX inhibitor in nanocapsule formulation | |
| Lemos-Senna et al. | Evaluation of the hydrophobic drug loading characteristics in nanoprecipitated amphiphilic cyclodextrin nanospheres | |
| Chen et al. | Rubusoside-assisted solubilization of poorly soluble C6-Ceramide for a pilot pharmacokinetic study | |
| Ghera et al. | Novel nanoparticles made from amphiphilic perfluoroalkyl α-cyclodextrin derivatives: Preparation, characterization and application to the transport of acyclovir | |
| Weisse et al. | Investigations on topically applied vitamin A loaded amphiphilic cyclodextrin nanocapsules | |
| Gopinath et al. | 1-O-Alkylglycerol vesicles (Algosomes): their formation and characterization |